Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer
about
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerFrequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysisVariable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cellsBioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue.Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway.The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer.Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.Gene expression of O-GlcNAc cycling enzymes in human breast cancersCritical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasisO-GlcNAcylation: A New Cancer Hallmark?Drosophila pico and its mammalian ortholog lamellipodin activate serum response factor and promote cell proliferationMacrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma.Copy number variation in archival melanoma biopsies versus benign melanocytic lesions.High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.Amplification and deletion of the RAPH1 gene in breast cancer patients.CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.Function of the macrophage-capping protein in colorectal carcinoma.Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.
P2860
Q21195213-FF739474-52C4-4394-B8A6-1DC787CDBD17Q21260401-E44105B9-9A7C-4F2D-A59B-E0C5801F554DQ28533234-0C566555-F533-4E6A-8EF8-7DB67BFBA438Q33241205-A5D2C2DA-C13D-4B1B-835D-E8625B73C382Q33318574-9C52388E-B84E-4DB1-8FF6-74D8AF5CCABEQ33337458-56404964-F67F-4F60-9705-049C66DD9533Q33598945-444D2650-FA96-4D75-93AF-E23A3E1F365FQ33850060-BA575A45-BA46-4710-92A7-00B367BEC85BQ33911433-CE6F0D79-4F3E-4843-ABE9-26A20F84AAE5Q34454256-B62DD496-5FA5-4653-90D3-098248EFBA79Q34488445-E7500FF1-EC1B-4690-AEAD-C3832394F2B5Q34939050-BFB27915-69E5-44BA-B34D-0BFEFBFF0ED3Q35809895-6E76E493-9C44-4819-BB9F-4515180C1218Q35879559-2DE3F02E-DFCC-4C2C-81C6-03CCF36F7FD9Q37086952-2EDF6DBB-3EFF-4F01-A365-F3073864F006Q37215670-068764C7-E657-4553-8243-D2450B0ACC6FQ37718887-76387A59-940B-49FC-81A7-781C6B12CB08Q38381518-FDFE8392-6786-438B-98F7-40E1DAC7E6C6Q39229600-47659A7F-F0D9-46A8-AE3A-8A1246E6769AQ39475921-922A1EB8-9C6C-4702-88D3-E6B09C0D5A9FQ40102564-8FD95B87-9383-4763-BAC6-E1264433CC1DQ40138994-E745C18A-7F5E-49A4-88A5-A0F95D4C1956Q42011951-07CA9203-344A-4449-B53B-3ABDD287AC80Q45404472-99130B10-6438-463C-A2E9-A480778388FCQ49331585-D1E15D32-50FE-4EA8-A9C3-E1B7D6D7E5BDQ55497180-DD79DC9F-0677-42CA-A67B-C4A444BCF817
P2860
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Systematic identification and ...... d in breast and ovarian cancer
@ast
Systematic identification and ...... d in breast and ovarian cancer
@en
Systematic identification and ...... d in breast and ovarian cancer
@nl
type
label
Systematic identification and ...... d in breast and ovarian cancer
@ast
Systematic identification and ...... d in breast and ovarian cancer
@en
Systematic identification and ...... d in breast and ovarian cancer
@nl
prefLabel
Systematic identification and ...... d in breast and ovarian cancer
@ast
Systematic identification and ...... d in breast and ovarian cancer
@en
Systematic identification and ...... d in breast and ovarian cancer
@nl
P2093
P2860
P50
P356
P1476
Systematic identification and ...... d in breast and ovarian cancer
@en
P2093
Achim Schneider
André Rosenthal
Ariane Sadr-Nabavi
Beate Betz
Beate Petschke
Bernd Hinzmann
Christine Sers
Dieter Niederacher
Glen Kristiansen
Han-Xiang An
P2860
P356
10.1002/PATH.1687
P407
P577
2005-01-01T00:00:00Z